Oxabrexine

This classification denotes a mucolytic agent and antitussive agent with the molecular formula C18H25Br2NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F220MU498K, chemically known as ethyl-((4,6-dibromo-alpha-(cyclohexylmethylamino)-o-tolyl)oxy)acetate but generally known as oxabrexine, which bears US NIH Compound Identifier 167463. European Medicines Agency schedules Oxabrexine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09482MIG. The term OXABREXINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). OXABREXINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule oxabrexine under HS 29222900 and SITC 51462. As of Q4 2014, OXABREXINE remains the US FDA Preferred Term for this commodity. Oxabrexine bears US NLM identifiers UMLS ID C2983807 and NCI Concept Code C90624. SMILES: Brc1c(OCC(=O)OCC)c(CN(C2CCCCC2)C)cc(Br)c1.